abagovomab 40
abciximab 38
abituzumab 24
abrilumab 24
actoxumab 23
adalimumab 22
aducanumab 17
afasevikumab 22
alacizumab_pegol 15
alemtuzumab 38
alirocumab 25
amatuximab 51
andecaliximab 29
anifrolumab 26
anrukinzumab 24
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 26
ascrinvacumab 8
atezolizumab 16
atinumab 19
avelumab 17
basiliximab 39
bavituximab 45
begelomab 35
benralizumab 34
bevacizumab_beta 27
bezlotoxumab 23
bimagrumab 23
bleselumab 24
blinatumomab 40
blosozumab 33
bococizumab 22
brazikumab 19
brentuximab_vedotin 39
briakinumab 21
brodalumab 24
brolucizumab 30
brontictuzumab 30
burosumab 25
cabiralizumab 31
camrelizumab 17
canakinumab 28
cantuzumab_ravtansin 53
carlumab 19
carotuximab 30
cergutuzumab_amunaleukin2 34
cergutuzumab_amunaleukin 34
certolizumab_pegol 27
cetiximab 52
citatuzumab_bogatox 30
cixutumumab 32
clivatuzumab_tetraxetan 33
codrituzumab 35
conatumumab 17
concizumab 34
crenezumab 25
crizanlizumab 30
crotedumab 24
dacetuzumab 26
daclizumab 23
dalotuzumab 45
dapirolizumab_pegol 30
daratumumab 16
dectrekumab 13
demcizumab 32
denosumab 12
depatuxizumab 33
depatuxizumab_mafodotin 33
dezamizumab 26
dinutuximab 43
diridavumab 32
domagrozumab 19
drozitumab 26
duligotuzumab 21
durvalumab 17
dusigitumab 27
efalizumab 38
efungumab 32
eldelumab 21
elezanumab 27
elgemtumab 15
elotuzumab 22
emactuzumab 29
emapalumab 31
emibetuzumab 27
enavatuzumab 28
enfortumab_vedotin 15
enoblituzumab 22
enokizumab 28
enoticumab 23
ensituximab 43
eptinezumab 21
erenumab 25
etaracizumab 18
etrolizumab 25
evinacumab 25
evolocumab 23
farletuzumab 16
fasinumab 30
fezakinumab 28
fibatuzumab 18
ficlatuzumab 26
firivumab 39
flanvotumab 26
fletikumab 34
foralumab 18
foravirumab 18
fremanezumab 32
fresolimumab 20
fulranumab 24
futuximab 36
galcanezumab 23
ganitumab 32
gantenerumab 16
gemetuzumab 36
gemtuzumab2 34
gemtuzumab 32
gevokizumab 30
girentuximab 36
glembatumumab 23
glembatumumab_vedotin 23
guselkumab 25
ibalizumab 31
ibritumomab 44
icrucumab 16
idarucizumab 42
ifabotuzumab 18
imalumab 19
imgatuzumab 26
inclacumab 24
indatuximab_ravtansin 41
indusatumab 24
inebilizumab 31
intetumumab 20
iodine_girentuximab 33
ipilimumab 11
iratumumab 19
isatuximab 42
itolizumab 29
ixekizumab 37
labetuzumab_govitecan 28
lambrolizumab 32
lampalizumab 31
lanadelumab 19
landogrozumab 19
laprituximab 33
lebrikizumab 42
lendalizumab 28
lenzilumab 23
lifastuzumab_vedotin 27
ligelizumab 25
lilotomab 46
lirilumab 29
lodelcizumab 22
lokivetmab 27
lorvotuzumab_mertansin 30
lucatumumab 32
lumretuzumab 25
lupartumab 19
lutikizumab 23
margetuximab 44
milatuzumab 46
mirvetuximab 43
mirvetuximab_soravtansin 43
modotuximab 48
mogamulizumab 37
monalizumab 27
motavizumab 44
moxetumomab_pasudotox 35
namilumab 30
naratuximab 37
naratuximab_emtansin 37
narnatumab 23
navicixizumab2 30
navicixizumab 33
navivumab 41
necitumumab 14
nemolizumab 32
nesvacumab 20
nivolumab 15
obiltoxaximab 25
obinutuzumab 37
ocaratuzumab 29
ofatumumab 22
olaratumab 23
olokizumab 28
omalizumab 22
onartuzumab 26
ontuxizumab 37
opicinumab 17
orticumab 17
otelixizumab 43
oxelumab 14
ozanezumab 38
pamrevlumab 14
panobacumab 32
parsatuzumab 31
pasotuxizumab 23
pateclizumab 22
patritumab 30
pembrolizumab 32
perakizumab 25
pidilizumab 27
pinatuzumab_vedotin 19
plozalizumab 34
pogalizumab 28
polatuzumab_vedotin 24
ponezumab 41
prezalumab 18
pritoxaximab 47
quilizumab 23
racotumomab 36
radretumab 18
ralpancizumab 24
ramucirumab 16
ranevetmab 35
ranibizumab 27
refanezumab 29
remtolumab 21
rilotumumab 26
rinucumab 23
risankizumab 39
rituximab 28
rivabazumab 26
robatumumab 20
roledumab 37
romosozumab 30
rontalizumab 27
rosmantuzumab 31
rozanolixizumab 27
sacituzumab 36
sacituzumab_govitecan 36
samalizumab 29
sapelizumab 25
sarilumab 19
secukinumab 22
seribantumab 18
setoxaximab 53
sifalimumab 22
siltuximab 34
simtuzumab 32
sirukumab 15
solanezumab 29
solitomab 34
stamulumab 25
suptavumab 30
suvizumab 27
tabalumab 22
tadocizumab 22
tamtuvetmab 38
tanezumab 28
tarextumab 15
tavolixizumab 23
telisotuzumab 33
teplizumab 28
tesidolumab 33
tezepelumab 32
tigatuzumab 19
tildrakizumab 25
timolumab 20
tisotumab 17
tosatoxumab 43
tositumomab 41
tralokinumab 38
trastuzumab 24
tregalizumab 25
trevogrumab 15
ublituximab 37
urelumab 29
ustekinumab 31
utomilumab 29
vadastuximab 33
vadastuximab_talirin 33
vandortuzumab_vedotin 24
vantictumab 26
vanucizumab2 27
vanucizumab 36
varlilumab 19
vatelizumab 29
vedolizumab 34
veltuzumab 22
vesencumab 13
vorsetuzumab 26
vorsetuzumab_mafodotin 26
vunakizumab 44
xentuzumab 22
zatuximab 48
